A detailed history of Quest Partners LLC transactions in Liquidia Corp stock. As of the latest transaction made, Quest Partners LLC holds 1,459 shares of LQDA stock, worth $15,523. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,459
Previous 2,278 35.95%
Holding current value
$15,523
Previous $27.3 Million 46.63%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$8.9 - $14.11 $7,289 - $11,556
-819 Reduced 35.95%
1,459 $14.6 Million
Q2 2024

Aug 06, 2024

BUY
$11.96 - $15.71 $27,244 - $35,787
2,278 New
2,278 $27.3 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $685M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.